Although the dependency on BCL-xL is often caused by alterations in the expression of other BCL-2 family proteins, such as MCL-1 and NOXA [24,47,48], the combination of everolimus and gemcitabine in malignant meningioma cells did not consistently alter the expression of these proteins in the present study. This evidence concerns the gene BCL2 and meningioma.